Table 3.

Treatments received by patient according to high risk or non high risk status (OlympiA study criteria) in ER-negative (triple negative) or ER-positive (ER+/HER2-) early breast cancer.

Treatment	ER- breast cancer (triple negative)					ER + breast cancer (ER+/HER2-)
	High risk (N = 211)		Non high risk (N = 169)		p value	High risk (N = 283)		Non high risk (N = 2820)		p value
	N	%	N	%		N	%	N	%
Chemotherapy					0.0225a					<0.0001
Yes adjuvant	124	58.8	102	60.4		165	58.7	672	23.9
Yes neoadjuvant	50	23.7	34	20.1		52	18.5	106	3.7
Yes both	8	3.8	0	0		8	2.9	11	0.4
No	29	13.7	33	19.5		56	19.9	2.024	72.0
Unknown	0		0			2		7
Endocrine therapy					1.000a					<0.0001
Yes adjuvant	2	1.0	2	1.2		265	94.3	2.232	79.3
Yes both neo- and adjuvant	0	0	0	0		3	1.1	21	0.8
No	209	99.0	167	98.8		13	4.6	561	19.9
Unknown	0		0			2		6
Radiotherapy					0.5809					<0.0001
Yes	182	86.3	149	88.2		265	94.3	2.417	85.9
No	29	13.7	20	11.8		16	5.7	397	14.1
Unknown	0		0			2		6

^aFisher's exact test.